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1. Introduction 
A severe chronic haemolytic anaemia was found 
to be due to a new highly unstable haemoglobin in 
which alanine 027 (B9) is replaced by aspartic acid. 
The variant, which has been named Hb Volga, cannot 
be separated from Hb A by routine electrophoretic 
methods, suggesting that the charge on the aspartic 
acid side-chain is suppressed by being ‘buried’ in a 
hydrophobic region of the molecule. 
2. Methods 
2.1. Routine investigations 
Haemolysates were subjected to electrophoresis on 
paper [I], starch gel (pH 7 and pH 8.6) [2], agar 
gel [3] and cellulose acetate [4], the latter being used 
to quantitate Hb A*_ Starch gel electrophoresis of 
ferricyanide treated haemolysate was carried out at 
pH 7 and pH 8.6. Isoelectric focusing on polyacryl- 
amide gel [S] was performed over the pH ranges 
3.5-9.5 and 6-9. Isopropanol stability tests were 
carried out according to Carrel1 and Kay [6] and Hb 
F was estimated by alkali denaturation [7]. Globin 
electrophoresis was carried out in 6 M urea [8]. 
Other haematological studies followed standard 
methods [9]. 
*.4bbreviation: TPCK, 1-chloro-4-phenyl-3-L-tosyl-amidobutan- 
2-one. 
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2.2. Structural studies 
Globin was prepared from the isopropanol 
precipitate and separated into its component chains 
[lo] . After gel filtration on a column (100 X 2.5 cm) 
of Sephadex G-25 (coarse) in 0.5% (v/v) aqueous 
acetic acid, the (Y- and P-chains were recovered by 
freeze drying. The P-chains were aminoethylated 
[ 1 l] and again subjected to gel filtration and freeze 
drying. Preparative ‘fingerprints’ of tryptic digests 
of the unmodified a-chain and aminoethylated (AE) 
P-chains were prepared at pH 6.4 and stained with 
fluorescamine, as recently described [ 121. (Trypsin 
(Worthington TRL 335786) was purified on CM- 
cellulose [ 131 and treated with TPCK* [ 141 before 
use). The abnormal tryptic peptide was eluted with 
0.5 N NH,OH; a portion was analysed and the 
remainder hydrolysed with thermolysin, followed 
by ‘fingerprints’ of the resultant peptide mixture, all 
as described previously [ 151. L-aspartic acid, L-lysine.- 
HCl, NE-dinitro phenol-L-lysine.HCl and cyan01 FF 
were used as electrophoresis markers. The net charges 
of peptides at pH 6.4 were calculated according to 
Offord [ 161. 
3. Results 
3.1. Haematologv and haemoglobin electrophoresis 
The patient was a 16 year old male from the Volga 
region. He had suffered from severe, chronic haemo- 
lytic anaemia from the first year of life and was 
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Table 1 
Haematological data for the Hb Volga heterozygote 
Before 
splenectomy 
RBC WBC Reticulocytes Platelets 
x 10-6/fil xlo-3/~1 % x lo-“/&d 
- ~__ 
3.04 3.75 20-30 85 
After 
splenectomy 10-13 3.85 9.70 20-40 280 
splenectomised at the age of five. Following splenec- 
tomy, numerous Heinz bodies were noted in the 
erythrocytes. The Hb F and Hb A2 levels were raised 
to 3.2% and 4.8% respectively; the isopropanol stability 
test produced a copious red precipitate after only three 
min. incubation. On starch gel electrophoresis a raised 
Hb Aa was noted and a small band in the region where 
free a-chains would be expected to move; otherwise no 
abnormality was noticed on electrophoresis or on iso- 
focusing of the oxy- or met-haemoglobin derivatives. 
Globin electrophoresis in 6 M urea, however, indicated 
the presence of fast-moving (pJ) chains which represent- 
ed about 15520% of the total &chains. The relevant 
pre- and post-splenectomy haematological data for the 
patient are shown in table 1. The patient’s parents and 
his sister did not have the unstable haemoglobin, which 
is therefore probably the result of a new mutation. 
3.2. Structural studies 
The CM-cellulose elution pattern of the globin from 
the isopropanol precipitate showed the latter to con- 
sist almost entirely of abnormal P-chains. The ‘iinger- 
print’ of the abnormal AE@ chain tryptic peptides 
showed that /3* Tp III, which consists of residues 
18-30 of the fl chain, (a in iig.1) was replaced by a 
new, more negatively-charged peptide (b in fig.1). The 
amino acid composition of the new peptide (table 2) 
differed from normal by the absence of alanine and the 
presence of an extra residue of aspartic acid. Since 
there is only one residue of alanine in PA Tp III, at 
position 027 (B9) (see tig.2), the mutation in the 
unstable Hb is /327 (B9) Ala + Asx. It is not possible to 
decide from the amino acid composition alone whether 
Asx is Asp or Asn, since Asn is converted to Asp 
during the acid hydrolysis preceding amino acid analy- 
0 
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Fig.1. ‘Fingerprint’ of the tryptic peptides of the AE@ chain from Hb Volga. Electrophoresis at pH 6.4 (60 V/cm, 1 h); ascending 
chromatography in the upper phase of pyridine-isoamyl alcohol-water (6:6:7, by vol.) for 22 h. Peptides were located by 
staining with fluorescamine as described in the methods section. (*) Origin; (a) Position of pA Tp III; (b) pVolga Tp III. 
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Table 2 
Fiaemoglobin Volga 
amino acid composition ofpTp III (~18-30) 
from the isopropanol precipitate 
Amino acid Molar ratio Expected for pA Tp III 
Asp 2.9 - _z_ 
Glu 2.0 2 
GlY 2.8 3 
Ala 0 r 
VaI 3.3 3 
Letl 1.0 1 
Arg 1.0 1 
sis. In view, however, of the increased negative charge 
of the abnormal haemoglobin chains in concentrated 
urea at pH 8.6 and pH 6.7, and of the increased anodal 
mobility of the variant PTp 111 at pH 6.4, it seemed 
likely that the substitution was Ala + Asp. This was 
confirmed by calculating the net charge on the abnor- 
Residue No. 18 19 20 21 22 23 
Helical No. A15 Bl B2 B3 B4 B5 
Residues 
Hb A Val Asn i Val Asp Glu J- VaI 
Hb Volga VaI Asn$Val Asp Glu J Val 
ma1 thermolysin peptide /323-27 (see fig.3); it is 1.64 
at pH 6.4, whereas the net charge of PA 23-27 is -0.8 1 
at pH 6.4. It follows that the substitution at position 
p27 (B9) is Ala + Asp. There is no reason to suppose 
that the substitution is Ala + Asn and that the resul- 
tant Asn -Leu (p27 -28) sequence has undergone 
subsequent deamidation (as is often observed with 
Asn-Gly sequences [ 171). No haemoglobin with the 
substitution 027 Ala + Asp has been described before, 
and in view of the patient’s origin it was decided to 
name the new variant Hb Volga. 
4. Discussion 
The clinical and haematological picture of the pa- 
tient is typical of a severe unstable haemoglobin 
haemolytic anaemia. The severity can be directly relat- 
ed to the instability of Hb Volga, which was observed 
to precipitate spontaneously from a haemolysate at 
24 25 26 21 28 29 30 
86 B7 B8 B9 I310 1111 B12 
GIY GlY Glu Alal Leu GlY Arg 
Gly Gly Glu Asp J Leu Gly Arg 
The arrows indicate the positions of hydrolysis by thermolysin. 
Fig.2. Amino acid sequence of the tryptic peptide III of the p-chain of normal haemoglobin and llb Volga. 
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Fig.3. ‘Fingerprint’ of the thermolysin peptides of pA Tp III and p ‘Olga Tp III prepared as described previously [ 151. (*) Origin. 
The positions occupied by the electrophoresis markers are indicated at the bottom; the mobility of the blue cyan01 FF dye is 
0.38 of that of aspartic acid at pH 6.4 [ 191. 
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4°C. Since both this precipitate and the isopropanol 
precipitate were red, it seems unlikely that Hb Volga 
undergoes a significant loss of haem groups from the 
abnormal chains, particularly as the isopropanol 
precipitate consisted almost exclusively of the abnormal 
P-chains. It appears that Hb Volga is the result of a 
spontaneous mutation, a finding which is becoming 
increasingly common to the highly unstable haemoglo- 
bins. 
Hb Volga represents the first known mutation at 
position B9 in any human globin chain. B9 is occupied 
by alanine in most of the known haemoglobin chains, 
although it can be occupied by threonine (as, for 
example, in the human y-chain [ 181 ; it is occupied by 
valine or isoleucine in all known vertebrate myoglobins. 
Dr M. F. Peru& showed us on his model of the haemo- 
globin molecule that the methyl group side-chain of Ala 
/3(B9) normally points away from the fl-haem group 
towards a very hydrophobic internal region comprising 
Val B5, Leu E12, L.eu G12, Val Cl5 and Leu G16 of 
same P-chain. Since the variant does not separate from 
Hb A, it seems likely that the charge on the aspartyl 
side-chain in Hb Volga is suppressed whilst it is in posi- 
tion within the tetramer. However, the introduction of 
a polar group into such a hydrophobic region cannot be 
accommodated easily, and as there is no way in which 
the new side-chain can be extruded to the surface of 
the molecule without causing gross molecular distur- 
bance, the substitution must give rise to a highly 
unstable haemoglobin. 
Although unstable haemoglobin variants are known 
in which a newly-introduced charge is internally com- 
pensated (as in Hb Wien [iO] and Hb Tacoma [21]), 
Hb Volga is the first instance of an unstable haemoglo- 
bin in which the ionisation of a new charge is suppress- 
ed by virtue of its intramolecular environment. 
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